Spearman's partial correlation coefficients and p-value (in parentheses) between clinical scores and R2* values or serum cholesterol levels.

Spearman's Correlation Between Levodopa Equivalent Dose (LED) Change From Baseline to 1-year Compared to Mood and Behavior Changes.

Michael S. Okun (137022)
Samuel S. Wu (256330)
Sarah Fayad (668729)
Herbert Ward (334115)
Dawn Bowers (668730)
Christian Rosado (668731)
Lauren Bowen (668732)
Charles Jacobson (334116)
Christopher Butson (668733)
Kelly D. Foote (137018)

December 2014

Spearman's Correlation Between Levodopa Equivalent Dose (LED) Change From Baseline to 1-year Comp...

Correlation of punding severity and Parkinson’s disease (PD) duration, PD medication duration, and levodopa-equivalent dose (LED).

Han Soo Yoo (776329)
Hyuk Jin Yun (281662)
Seok Jong Chung (497755)
Mun Kyung Sunwoo (776330)
Jong-Min Lee (105338)
Young Ho Sohn (776331)
Phil Hyu Lee (116745)

July 2015

Punding severity was significantly correlated with (A) LED (r = 0.69, p = 0.029) an...

Predicting the longitudinal changes of levodopa dose requirements in Parkinson’s disease using item response theory assessment of real‐world Unified Parkinson's Disease Rating Scale

Dongwoo Chae
Su Jin Chung
Phil Hyu Lee
Kyungsoo Park

June 2021

Abstract Item response theory (IRT) has been recently adopted to successfully characterize the progr...

Spearman's rank correlation coefficient (rs) and P values between UPDRS III and clinical variables, and between H&Y and clinical variables.

Limin Zhang (297459)
Junqiang Yan (349427)
Yunqi Xu (349428)
Ling Long (352768)
Cansheng Zhu (311731)
Xiaohong Chen (220164)
Ying Jiang (5910)
Lijuan Yang (1538233)
Lianfang Bian (352769)
Qing Wang (27728)

February 2013

* P<0.05,** P<0.001.Abbreviations: rs, Spearman's rank cor...

Correlations between the number of impaired nerves and patient parameters.

Constanze Jugel (424384)
Felicitas Ehlen (424385)
Birol Taskin (424386)
Frank Marzinzik (328653)
Thomas Müller (3554)
Fabian Klostermann (328660)

June 2013

The first two data columns provide the correlation values per parameter in each group. The last c...

Univariate linear correlations between the baseline and clinical characteristics with Parkinson’s disease summary index (PDSI) of the health-related quality of life (HRQoL) (n = 157).

Seyed-Mohammad Fereshtehnejad (532457)
Mahdiyeh Shafieesabet (532459)
Farzaneh Farhadi (791922)
Hasti Hadizadeh (791923)
Arash Rahmani (791924)
Nader Naderi (791925)
Dena Khaefpanah (791926)
Gholam Ali Shahidi (532460)
Ahmad Delbari (532461)
Johan Lökk (532462)

September 2015

PIGD: postural-instability-gait-difficulty; FOSS: freezing-speech-swallowing* Statistical ...

Demographic and clinical data of drug-naïve patients with Parkinson's disease.

Masahiro Mishina (355347)
Kiichi Ishiwata (354966)
Mika Naganawa (355348)
Yuichi Kimura (355350)
Shin Kitamura (355351)
Masahiko Suzuki (355352)
Masaya Hashimoto (355353)
Kenji Ishibashi (354964)
Keiichi Oda (305055)
Muneyuki Sakata (355354)
Makoto Hamamoto (355355)
Shiro Kobayashi (355356)
Yasuo Katayama (355357)
Kenji Ishii (305052)

February 2013

UPDRS-III; Unified Parkinson's Disease Rating Scale part III. LED; levodopa-equivalent dose.</p

Method of Levodopa Response Calculation Determines Strength of Association With Clinical Factors in Parkinson Disease

Marcus Pieterman
Scott Adams
Scott Adams
Mandar Jog

May 2018

BackgroundThe levodopa challenge test is routinely used in Parkinson disease (PD) to determine a pat...

Correlation between nigrostriatal iron and serum cholesterol levels.

Guangwei Du (170522)
Mechelle M. Lewis (170530)
Michele L. Shaffer (170539)
Honglei Chen (125181)
Qing X. Yang (170550)
Richard B. Mailman (170558)
Xuemei Huang (170562)

April 2012

Partial residual plots of nigrostriatal iron deposition and serum cholesterol levels in Parkinson...

Demographic and clinical data of dyskinesic patients with Parkinson's disease.

Masahiro Mishina (355347)
Kiichi Ishiwata (354966)
Mika Naganawa (355348)
Yuichi Kimura (355350)
Shin Kitamura (355351)
Masahiko Suzuki (355352)
Masaya Hashimoto (355353)
Kenji Ishibashi (354964)
Keiichi Oda (305055)
Muneyuki Sakata (355354)
Makoto Hamamoto (355355)
Shiro Kobayashi (355356)
Yasuo Katayama (355357)
Kenji Ishii (305052)

February 2013

UPDRS-III; Unified Parkinson's Disease Rating Scale part III. LED; levodopa-equivalent dose.</p

The group response of Parkinson’s disease patients to levodopa, accounting for individual motor aspects of the disease.

Štefan Holiga (121788)
Karsten Mueller (121785)
Harald E. Möller (167215)
Tomáš Sieger (121787)
Matthias L. Schroeter (167223)
Josef Vymazal (121796)
Evžen Růžička (121800)
Robert Jech (121784)

February 2013

First column (a) shows results obtained by a conventional analysis not comprising the UPDRS-III s...

Stepwise linear regression for the four impulsivity factors and clinical or demographic variables.

Cristina Nombela (511440)
Timothy Rittman (511441)
Trevor W. Robbins (481482)
James B. Rowe (456704)

January 2014

For each row, the impulsivity factor corresponds to the four factors in <a href="http://www.ploso...

Changes in Unified Parkinson’s Disease Rating Scale Part III (UPDRS-III) scores (A) and L-dopa equivalent dose (LED) (B) by tertile of baseline C-reactive protein (CRP) concentrations.

Atsushi Umemura (158649)
Tomoko Oeda (233773)
Kenji Yamamoto (233783)
Satoshi Tomita (403444)
Masayuki Kohsaka (403445)
Kwiyoung Park (571065)
Hiroshi Sugiyama (14595)
Hideyuki Sawada (233770)

August 2015

UPDRS-III score and LED (mg/day) were measured at the study enrollment and during the follow-up p...

Spearman correlation coefficients between clinical variables and sleep variables.

Irene M. Lelieveld (316821)
Martijn L. T. M. Müller (316824)
Nicolaas I. Bohnen (316826)
Robert A. Koeppe (316827)
Ronald D. Chervin (316828)
Kirk A. Frey (316829)
Roger L. Albin (316830)

February 2013

*Significant after FDR correction; BMI = Body Mass Index; UPDRS = Unified Parkinson.Di...

Correlation between clinical variable groups measures of PD manifestation and individual measures of VMC performance with each hand.

Rivka Inzelberg (182830)
Edna Schechtman (376074)
Shraga Hocherman (376075)

February 2013

R: Spearman correlation coefficient. P: Significance of the correlation coefficient. Significant ...

Spearman's Correlation Between Levodopa Equivalent Dose (LED) Change From Baseline to 1-year Compared to Mood and Behavior Changes.

Michael S. Okun (137022)
Samuel S. Wu (256330)
Sarah Fayad (668729)
Herbert Ward (334115)
Dawn Bowers (668730)
Christian Rosado (668731)
Lauren Bowen (668732)
Charles Jacobson (334116)
Christopher Butson (668733)
Kelly D. Foote (137018)

December 2014

Spearman's Correlation Between Levodopa Equivalent Dose (LED) Change From Baseline to 1-year Comp...

Correlation of punding severity and Parkinson’s disease (PD) duration, PD medication duration, and levodopa-equivalent dose (LED).

Han Soo Yoo (776329)
Hyuk Jin Yun (281662)
Seok Jong Chung (497755)
Mun Kyung Sunwoo (776330)
Jong-Min Lee (105338)
Young Ho Sohn (776331)
Phil Hyu Lee (116745)

July 2015

Punding severity was significantly correlated with (A) LED (r = 0.69, p = 0.029) an...

Predicting the longitudinal changes of levodopa dose requirements in Parkinson’s disease using item response theory assessment of real‐world Unified Parkinson's Disease Rating Scale

Dongwoo Chae
Su Jin Chung
Phil Hyu Lee
Kyungsoo Park

June 2021

Abstract Item response theory (IRT) has been recently adopted to successfully characterize the progr...

Spearman's rank correlation coefficient (rs) and P values between UPDRS III and clinical variables, and between H&Y and clinical variables.

Limin Zhang (297459)
Junqiang Yan (349427)
Yunqi Xu (349428)
Ling Long (352768)
Cansheng Zhu (311731)
Xiaohong Chen (220164)
Ying Jiang (5910)
Lijuan Yang (1538233)
Lianfang Bian (352769)
Qing Wang (27728)

February 2013

* P<0.05,** P<0.001.Abbreviations: rs, Spearman's rank cor...

Correlations between the number of impaired nerves and patient parameters.

Constanze Jugel (424384)
Felicitas Ehlen (424385)
Birol Taskin (424386)
Frank Marzinzik (328653)
Thomas Müller (3554)
Fabian Klostermann (328660)

June 2013

The first two data columns provide the correlation values per parameter in each group. The last c...

Univariate linear correlations between the baseline and clinical characteristics with Parkinson’s disease summary index (PDSI) of the health-related quality of life (HRQoL) (n = 157).

Seyed-Mohammad Fereshtehnejad (532457)
Mahdiyeh Shafieesabet (532459)
Farzaneh Farhadi (791922)
Hasti Hadizadeh (791923)
Arash Rahmani (791924)
Nader Naderi (791925)
Dena Khaefpanah (791926)
Gholam Ali Shahidi (532460)
Ahmad Delbari (532461)
Johan Lökk (532462)

September 2015

PIGD: postural-instability-gait-difficulty; FOSS: freezing-speech-swallowing* Statistical ...

Demographic and clinical data of drug-naïve patients with Parkinson's disease.

Masahiro Mishina (355347)
Kiichi Ishiwata (354966)
Mika Naganawa (355348)
Yuichi Kimura (355350)
Shin Kitamura (355351)
Masahiko Suzuki (355352)
Masaya Hashimoto (355353)
Kenji Ishibashi (354964)
Keiichi Oda (305055)
Muneyuki Sakata (355354)
Makoto Hamamoto (355355)
Shiro Kobayashi (355356)
Yasuo Katayama (355357)
Kenji Ishii (305052)

February 2013

UPDRS-III; Unified Parkinson's Disease Rating Scale part III. LED; levodopa-equivalent dose.</p

Method of Levodopa Response Calculation Determines Strength of Association With Clinical Factors in Parkinson Disease

Marcus Pieterman
Scott Adams
Scott Adams
Mandar Jog

May 2018

BackgroundThe levodopa challenge test is routinely used in Parkinson disease (PD) to determine a pat...

Correlation between nigrostriatal iron and serum cholesterol levels.

Guangwei Du (170522)
Mechelle M. Lewis (170530)
Michele L. Shaffer (170539)
Honglei Chen (125181)
Qing X. Yang (170550)
Richard B. Mailman (170558)
Xuemei Huang (170562)

April 2012

Partial residual plots of nigrostriatal iron deposition and serum cholesterol levels in Parkinson...

Demographic and clinical data of dyskinesic patients with Parkinson's disease.

Masahiro Mishina (355347)
Kiichi Ishiwata (354966)
Mika Naganawa (355348)
Yuichi Kimura (355350)
Shin Kitamura (355351)
Masahiko Suzuki (355352)
Masaya Hashimoto (355353)
Kenji Ishibashi (354964)
Keiichi Oda (305055)
Muneyuki Sakata (355354)
Makoto Hamamoto (355355)
Shiro Kobayashi (355356)
Yasuo Katayama (355357)
Kenji Ishii (305052)

February 2013

UPDRS-III; Unified Parkinson's Disease Rating Scale part III. LED; levodopa-equivalent dose.</p

The group response of Parkinson’s disease patients to levodopa, accounting for individual motor aspects of the disease.

Štefan Holiga (121788)
Karsten Mueller (121785)
Harald E. Möller (167215)
Tomáš Sieger (121787)
Matthias L. Schroeter (167223)
Josef Vymazal (121796)
Evžen Růžička (121800)
Robert Jech (121784)

February 2013

First column (a) shows results obtained by a conventional analysis not comprising the UPDRS-III s...

Stepwise linear regression for the four impulsivity factors and clinical or demographic variables.

Cristina Nombela (511440)
Timothy Rittman (511441)
Trevor W. Robbins (481482)
James B. Rowe (456704)

January 2014

For each row, the impulsivity factor corresponds to the four factors in <a href="http://www.ploso...

Changes in Unified Parkinson’s Disease Rating Scale Part III (UPDRS-III) scores (A) and L-dopa equivalent dose (LED) (B) by tertile of baseline C-reactive protein (CRP) concentrations.

Atsushi Umemura (158649)
Tomoko Oeda (233773)
Kenji Yamamoto (233783)
Satoshi Tomita (403444)
Masayuki Kohsaka (403445)
Kwiyoung Park (571065)
Hiroshi Sugiyama (14595)
Hideyuki Sawada (233770)

August 2015

UPDRS-III score and LED (mg/day) were measured at the study enrollment and during the follow-up p...

Spearman correlation coefficients between clinical variables and sleep variables.

Irene M. Lelieveld (316821)
Martijn L. T. M. Müller (316824)
Nicolaas I. Bohnen (316826)
Robert A. Koeppe (316827)
Ronald D. Chervin (316828)
Kirk A. Frey (316829)
Roger L. Albin (316830)

February 2013

*Significant after FDR correction; BMI = Body Mass Index; UPDRS = Unified Parkinson.Di...

Correlation between clinical variable groups measures of PD manifestation and individual measures of VMC performance with each hand.

Rivka Inzelberg (182830)
Edna Schechtman (376074)
Shraga Hocherman (376075)

February 2013

R: Spearman correlation coefficient. P: Significance of the correlation coefficient. Significant ...

Spearman's Correlation Between Levodopa Equivalent Dose (LED) Change From Baseline to 1-year Compared to Mood and Behavior Changes.

Michael S. Okun (137022)
Samuel S. Wu (256330)
Sarah Fayad (668729)
Herbert Ward (334115)
Dawn Bowers (668730)
Christian Rosado (668731)
Lauren Bowen (668732)
Charles Jacobson (334116)
Christopher Butson (668733)
Kelly D. Foote (137018)

December 2014

Spearman's Correlation Between Levodopa Equivalent Dose (LED) Change From Baseline to 1-year Comp...

Correlation of punding severity and Parkinson’s disease (PD) duration, PD medication duration, and levodopa-equivalent dose (LED).

Han Soo Yoo (776329)
Hyuk Jin Yun (281662)
Seok Jong Chung (497755)
Mun Kyung Sunwoo (776330)
Jong-Min Lee (105338)
Young Ho Sohn (776331)
Phil Hyu Lee (116745)

July 2015

Punding severity was significantly correlated with (A) LED (r = 0.69, p = 0.029) an...

Predicting the longitudinal changes of levodopa dose requirements in Parkinson’s disease using item response theory assessment of real‐world Unified Parkinson's Disease Rating Scale

Dongwoo Chae
Su Jin Chung
Phil Hyu Lee
Kyungsoo Park

June 2021

Abstract Item response theory (IRT) has been recently adopted to successfully characterize the progr...

Spearman's partial correlation coefficients and p-value (in parentheses) between clinical scores and R2* values or serum cholesterol levels.

Abstract

Extracted data

Spearman's partial correlation coefficients and p-value (in parentheses) between clinical scores and R2* values or serum cholesterol levels.

Abstract

Extracted data

Related items

Related items